Dr. Ajay Aurora, A03243 AUTHORS Dr Ajay Aurora AIOS Membership Number A 03243 Prof Neetu Singh, MsVartikaDhyani Centre for Biomedical Engineering, IIT Delhi Dr Arjun Aurora Intern, Maulana Azad Medical College Address For Correspondence Dr Ajay Aurora Vision Plus Eye Centre Kisan Tower Golf Course…
FP121 : Costeffectiveness of ‘ Reteval’ an Electro-Physiological Tool for Diabetic Retinopathy Screening
Dr. Khandekar Rajiv, K9599.
In 2014, 387 million people were estimated to be living with diabetes, an alarming number that is set to rise to 592 million within the next twenty years.1 Diabetic retinopathy (DR) needs public health approach in coming years to prevent visual disabilities.2
FP127 : Detection of Subtle Cnvms in Eyes with Central Serous Chorioretinopathy Using OCT Angiography
Dr. Sangeet Mittal, M09477
Subretinal neovascular membrane (SRNVM) can complicate chronic central serous chorioretinopathy (CSR) and may be difficult to diagnose because CSR itself can be associated with pigment epithelial detachment, subretinal fluid and ill-defined patterns of hyperfluorescence on fundus fluorescein angiography (FFA) 1,2
FP1472 : Foveal Avascular Zone in Diabetic Eyes Evaluated By Optical Coherence Tomography Angiography (OCTA)
Dr. ApoorvGrover, G12464, Dr. Sonal Gupta, Dr. BipulBhushan, Dr. Alok Sen
Diabetic retinopathy is known to be one of the leading causes of blindness among the working age group (1,2). India, over the next two decades, is expected to become one of the major hubs of diabetic population according to the World Health Organisation (2).
Dr. Shraddha Pandey.S19417, Dr. Sujit Abhaykumar Deshmukh, Dr. KiranSingh, Dr.Shrikant
Diabetes is fast gaining the status of a potential epidemic in India with more than 62 million diabetic individuals currently diagnosed with the disease.
FP391 : Multifaceted Relationship Between Renal Parameters and Choroidal Thickness in Diabetic Retinopathy
Dr. Jay Sheth, S18167, Dr. Giridhar Anantharaman, Dr.Mahesh G
To illustrate changes in renal parameters(RP; Creatinine & Urea)& choroidal thickness(CT) in DR.
Dr. Sabyasachi Sengupta S14805, Dr. ManaviDeokrismna Sindal, Dr. Prabu Baskaran, Dr. UtsabPan
The global burden of diabetes is expected to rise from 285 million in 2010 to well over 439 million in 2030. As the prevalence of diabetes increases, the burden of diabetic retinopathy (DR) will also increase from its current prevalence of 93 million.
Dr.Sabyasachi Bandyopadhyay, S12267,Dr. Samir Kumar Bandyopadhyay, Dr Mita Saha (DuttaChowdhury), Dr. Abhik Sinha
To compare aqueous cytokine levels in diabetic macular edema (DME).
FP788 : Sub-Foveal Choroidal Thickness (SFCT) As a Marker of Disease Activity in Anti-Vegf Therapy of AMD.
Unnikrishnan Nair*,Manoj S, Lata Iyoob*
To evaluate the choroidal thickness in different variants of neovascular AMD like occult choroidal neovascularisation (occult AMD) & Polypoidal choroidal vasculopathy (PCV) and study the change in thickness during anti-VEGF treatment.
FP853 : Diabetic Retinopathy and Systemic Factors-Optical Coherence Tomography Angiography Correlation Study.
Dr. Santosh Gopi Krishna Gadde, G16678, Ms.Neha Anegondi, Dr. Abhijit Sinha Roy, Dr. Naresh Kumar Yadav
Diabetic mellitus (DM) is a chronic condition and is estimated to rise to 360 million by the year 2030 according to World Health Organization.1